
FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers
Author(s) -
Simona Stolnicu,
Monica Boros,
Lien Hoang,
Noorah Almadani,
Louise De Brot,
Glauco Baiocchi,
Graziele Bonvolim,
Carlos ParraHerran,
Sofia Lérias,
Ana Félix,
Andres A. Roma,
Anna Pesci,
Esther Oliva,
Kay J. Park,
Robert A. Soslow,
Nadeem R. AbuRustum
Publication year - 2020
Publication title -
international journal of gynecological cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.901
H-Index - 87
eISSN - 1525-1438
pISSN - 1048-891X
DOI - 10.1136/ijgc-2020-001893
Subject(s) - medicine , stage (stratigraphy) , adenosquamous carcinoma , lymph node , adenocarcinoma , oncology , gynecology , cancer , paleontology , biology
Prognostic factors for endocervical adernocarcinomas are well known, but little is known about prognostic biomarkers influencing outcome for the newly defined International Federation of Gynecology and Obstetrics (FIGO) 2018 IB sub-stages. The aim of this study was to identify prognostic biomarkers influencing recurrence-free and overall survival for FIGO 2018 stage IB cervical adenocarcinoma sub-types. We sought to identify these factors using a large international multi-institutional series of cases.